Birgit Schramm

1.8k total citations
38 papers, 1.1k citations indexed

About

Birgit Schramm is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Birgit Schramm has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Virology, 19 papers in Infectious Diseases and 8 papers in Epidemiology. Recurrent topics in Birgit Schramm's work include HIV Research and Treatment (18 papers), HIV/AIDS Research and Interventions (13 papers) and HIV/AIDS drug development and treatment (12 papers). Birgit Schramm is often cited by papers focused on HIV Research and Treatment (18 papers), HIV/AIDS Research and Interventions (13 papers) and HIV/AIDS drug development and treatment (12 papers). Birgit Schramm collaborates with scholars based in France, United States and Switzerland. Birgit Schramm's co-authors include Jacomine Krijnse Locker, Mark A. Goldsmith, Michael L. Penn, Leonid Margolis, Jean‐Charles Grivel, Dominik Alex Nowak, Cornelis A. M. de Haan, B. Ehlken, A. Smala and Karin Berger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of Virology.

In The Last Decade

Birgit Schramm

37 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Birgit Schramm France	18	570	400	260	180	175	38	1.1k
Thomas D. Martin United States	16	430 0.8×	279 0.7×	564 2.2×	90 0.5×	211 1.2×	21	1.1k
Thomas Hodge United States	21	533 0.9×	727 1.8×	535 2.1×	266 1.5×	448 2.6×	42	1.6k
Sabina Wünschmann United States	21	312 0.5×	162 0.4×	182 0.7×	79 0.4×	490 2.8×	35	1.6k
Jay A. Berzofsky United States	9	346 0.6×	232 0.6×	702 2.7×	75 0.4×	295 1.7×	11	1.2k
Fedde Groot Netherlands	13	621 1.1×	278 0.7×	434 1.7×	64 0.4×	157 0.9×	14	920
Edward JD Greenwood United Kingdom	12	189 0.3×	332 0.8×	294 1.1×	50 0.3×	105 0.6×	22	895
Marion F. Gruber United States	18	204 0.4×	266 0.7×	346 1.3×	57 0.3×	258 1.5×	37	901
Edward D. Blair United Kingdom	15	512 0.9×	482 1.2×	182 0.7×	32 0.2×	366 2.1×	28	1.1k
Elena Martinelli United States	17	403 0.7×	200 0.5×	465 1.8×	74 0.4×	294 1.7×	43	977
T. Debord France	14	481 0.8×	301 0.8×	428 1.6×	136 0.8×	253 1.4×	48	982

Countries citing papers authored by Birgit Schramm

Since Specialization

Citations

This map shows the geographic impact of Birgit Schramm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Schramm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Schramm more than expected).

Fields of papers citing papers by Birgit Schramm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit Schramm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Schramm. The network helps show where Birgit Schramm may publish in the future.

Co-authorship network of co-authors of Birgit Schramm

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit Schramm. A scholar is included among the top collaborators of Birgit Schramm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit Schramm. Birgit Schramm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Schramm, Birgit, et al.. (2025). Prevalence of hepatitis C virus seropositivity and active infection in a Rohingya refugee population in Cox's Bazar camps, Bangladesh: a cross-sectional study. The Lancet. Gastroenterology & hepatology. 10(7). 648–657. 1 indexed citations

2.

Schramm, Birgit, Elvis Temfack, Diane Descamps, et al.. (2022). Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort study. The Lancet HIV. 9(8). e544–e553. 48 indexed citations

3.

Schramm, Birgit, et al.. (2021). Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children. PLoS ONE. 16(5). e0250933–e0250933. 8 indexed citations

4.

Schramm, Birgit, et al.. (2021). Correction: Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children. PLoS ONE. 16(8). e0256717–e0256717. 1 indexed citations

5.

Schramm, Birgit, Stephen Wanjala, Lubbe Wiesner, et al.. (2021). High Prevalence of NRTI and NNRTI Drug Resistance Among ART-Experienced, Hospitalized Inpatients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 87(3). 883–888. 7 indexed citations

6.

Otienoburu, Sabina Dahlström, Oumou Maïga‐Ascofaré, Birgit Schramm, et al.. (2016). Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate–amodiaquine fixed dose combination or artemether–lumefantrine in Liberia. Malaria Journal. 15(1). 452–452. 37 indexed citations

7.

Schramm, Birgit, Stephen W. Nicholas, Eustice Mhango, et al.. (2015). Evaluation of HIV PIMA (TM) CD4 point-of-care test operation by trained non-health workers in rural health centres in Chiradzulu District, Malawi. Journal of the International AIDS Society. 18. 122–123. 1 indexed citations

8.

Pinoges, Loretxu, Birgit Schramm, Suna Balkan, et al.. (2015). Risk Factors and Mortality Associated With Resistance to First-Line Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 68(5). 527–535. 21 indexed citations

9.

Schramm, Birgit, Elisabeth Baudin, Richard A. Smith, et al.. (2013). Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trial. Malaria Journal. 12(1). 251–251. 25 indexed citations

10.

Nabasumba, Carolyn, Pierre De Beaudrap, Francesco Grandesso, et al.. (2011). Heterogenous decrease in malaria prevalence in children over a 6-year period in South-Western Uganda. Tropical Medicine & International Health. 16. 1 indexed citations

11.

Beaudrap, Pierre De, Carolyn Nabasumba, Francesco Grandesso, et al.. (2011). Heterogeneous decrease in malaria prevalence in children over a six-year period in south-western Uganda. Malaria Journal. 10(1). 132–132. 52 indexed citations

12.

Schramm, Birgit, Elisabeth Baudin, Ronald D. Smith, et al.. (2010). A PHASE 4 RANDOMISED STUDY TO ASSESS THE TOLERABILITY OF ARTESUNATE-AMODIAQUINE (ASAQ) AND ARTEMETHER-LUMEFANTRINE (AL) FIXED DOSE COMBINATIONS (FDCS) FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM (PF) MALARIA IN LIBERIA. American Journal of Tropical Medicine and Hygiene. 83. 371–371. 1 indexed citations

13.

Schramm, Birgit, Elisabeth Baudin, Ronald D. Smith, et al.. (2010). EFFICACY OF ARTESUNATE-AMODIAQUINE (ASAQ) AND ARTEMETHER-LUMEFANTRINE (AL) FIXED DOSE COMBINATIONS (FDCS) FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM (PF) MALARIA IN NIMBA COUNTY, LIBERIA. American Journal of Tropical Medicine and Hygiene. 83. 329–329. 1 indexed citations

14.

Pujades‐Rodríguez, Mar, Birgit Schramm, Eric Nerrienet, et al.. (2010). Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIV‐infected patients in Cambodia. Tropical Medicine & International Health. 16(2). 205–213. 12 indexed citations

15.

Schramm, Birgit, Cornelis A. M. de Haan, Joanne Young, et al.. (2006). Vaccinia‐Virus‐Induced Cellular Contractility Facilitates the Subcellular Localization of the Viral Replication Sites. Traffic. 7(10). 1352–1367. 36 indexed citations

16.

Schepis, Antonino, Birgit Schramm, Cornelis A. M. de Haan, & Jacomine Krijnse Locker. (2005). Vaccinia Virus‐Induced Microtubule‐Dependent Cellular Rearrangements. Traffic. 7(3). 308–323. 57 indexed citations

17.

Sodeik, Beate, Birgit Schramm, Maarit Suomalainen, & Jacomine Krijnse Locker. (2005). Meeting Report: EMBO Workshop ‘Cell Biology of Virus Infection’, September 25–29, 2004, EMBL, Heidelberg, Germany. Traffic. 6(4). 351–356. 2 indexed citations

18.

Grivel, Jean‐Charles, Michael L. Penn, Birgit Schramm, et al.. (2000). Human Immunodeficiency Virus Type 1 Coreceptor Preferences Determine Target T-Cell Depletion and Cellular Tropism in Human Lymphoid Tissue. Journal of Virology. 74(11). 5347–5351. 61 indexed citations

19.

Grivel, Jean‐Charles, Michael L. Penn, Birgit Schramm, et al.. (2000). Human Immunodeficiency Virus Type 1 Coreceptor Preferences Determine Target T-Cell Depletion and Cellular Tropism in Human Lymphoid Tissue. Journal of Virology. 74(11). 5347–5351. 2 indexed citations

20.

Fackler, O., Norbert Kienzle, Elisabeth Kremmer, et al.. (1997). Association of Human Immunodeficiency Virus Nef Protein with Actin is Myristoylation Dependent and Influences its Subcellular Localization. European Journal of Biochemistry. 247(3). 843–851. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact